Trial of Cholinergic Agonist in Adults with ADHD
A novel cholinergic activating agent, ABT-418, was used to treat 29 adults with ADHD, in a double-blind, placebo-controlled, randomized, crossover trial at the Pediatric Psychopharmacology Clinic, Massachusetts General Hospital, Boston.
Guardado en:
Autor principal: | J Gordon Millichap (Autor) |
---|---|
Formato: | Libro |
Publicado: |
Pediatric Neurology Briefs Publishers,
1999-12-01T00:00:00Z.
|
Materias: | |
Acceso en línea: | Connect to this object online. |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Dopamine Agonist in Treatment of ADHD with Restless Legs Syndrome and ODD
por: J Gordon Millichap
Publicado: (2005) -
Childhood ADHD and Adult Criminality
por: J Gordon Millichap
Publicado: (1997) -
Trial of Dexmethylphenidate (Focalin) ER in ADHD
por: J Gordon Millichap
Publicado: (2006) -
Atomoxetine Open-Label Trial in ADHD
por: J Gordon Millichap
Publicado: (2002) -
Service Needs of Young Adults with ADHD
por: J Gordon Millichap
Publicado: (2010)